Health Sciences
Navigating complexity with sector-specific precision
The biotech and medtech sectors are dynamic, capital-intensive and increasingly intertwined with innovation cycles that can be difficult to time.
Clarity at every stage
Strategic decisions grounded in science and business
At Turk & Company, we help founders, executives and investors make strategic decisions with clarity, whether they are raising capital, pursuing an exit or evaluating strategic partnerships.
Our experience spans early-stage ventures, growth-phase innovators and mature businesses across diagnostics, medical devices, life sciences tools and health technology platforms.
- Diagnostics
- Medical devices
- Life sciences tools
- Health technology platforms
Led by experience. Built for growth.
Led by Edward McKenna, PhD
Our biotech advisory practice brings together deep technical knowledge and real-world deal experience. With a background that spans product development, corporate strategy and commercialization, Dr. McKenna has advised companies from startup to scale-up to exit.
We understand what drives value in this space: IP strength, regulatory clarity, clinical differentiation and commercial potential. Our team speaks the language of science and business, bridging the gap between innovation and capital.
Strategic advisory for biotech leaders
Focus, insight and execution expertise
- 01Sell-side and buy-side M&A
- 02Capital raises and recapitalizations
- 03Strategic growth planning
- 04Partnering and licensing strategy
- 05Corporate development execution
Whether you are looking to position for acquisition, secure strategic investment or carve a new path in the market, Turk & Company brings the focus, insight and execution expertise to help you move forward.